1024免费一级欧美片在线观看_久久免费精品视频互動交流_国国产无套粉嫩白浆在线_饥渴难耐的浪荡艳妇_亚洲国产日韩一区在线_欧美激情性爱吧_精品人妻少妇av嫩草_嗯啊不要视频_另类欧美亚洲综合_网友自拍亚洲无码另类

杭州昊鑫生物科技股份有限公司
網(wǎng)站標(biāo)題
搜索

取消

清空記錄

歷史記錄

清空記錄

歷史記錄

清空記錄

歷史記錄

杭州昊鑫生物科技股份有限公司
    當(dāng)前位置:
  • 首頁(yè)>
  • 產(chǎn)品中心>
  • MCE>
  • CCT020312

產(chǎn)品中心

CCT020312

分享到微信

×
CCT020312 是選擇性的 EIF2AK3/PERK 的激huo劑。CCT020312 可誘導(dǎo)細(xì)胞細(xì)胞中 EIF2A 的磷酸化。貨號(hào):HY-119240 ,CAS:324759-76-4
參數(shù)品牌:MCE
產(chǎn)品參數(shù)
品牌:MCE
型號(hào):HY-119240
起訂量:1
規(guī)格::5mg
價(jià)格::¥1800
我知道了
在線客服
產(chǎn)品詳情

CCT020312

CCT020312 是選擇性的 EIF2AK3/PERK 的ji活劑。CCT020312 可誘導(dǎo)細(xì)胞細(xì)胞中 EIF2A 的磷酸化。

生物活性

CCT020312 is a selective EIF2AK3/PERK activator. CCT020312 elicits EIF2A phosphorylation in cells.


IC50 & Target

EIF2AK3/PERK[1][2].


體外研究(In Vitro)

Treatment of HT29 cells with CCT020312 for 24 hours reveals a concentration-dependent loss of P-S608-pRB signal, with a linear response between 1.8 and 6.1 μM[1].
CCT020312 treatment effectively inhibits cell proliferation (as measured at 96 hours) even if treatment is for 2 hours only with subsequent compound washout, indicating that CCT020312 is capable of eliciting durable rather than transient cytostasis[1].
Treatment of HT29 cells with 10 μM CCT020312 for 24 hours reduces the amount of the G1/S cyclins D1, D2, E and A as well as the CDK catalytic subunit CDK2 and increased the level of the CDK inhibitor p27KIP1 present in such cells[1].


體內(nèi)研究(In Vivo)

Treatment of 15-week-old wildtype mice with the PERK activator CCT020312 (1-5 mg/kg; i.p.; once daily for 3 days) leads to increased levels of phosphorylated PERK and NRF2 in brain homogenates[2].
P301S transgenic mice treated with CCT020312 (2 mg/kg; i.p.; once daily for 6 weeks) performes significantly better in Morris water maze[2].

Animal Model:9-week-old P301S tau transgenic mice[2]
Dosage:2 mg/kg
Administration:Intraperitoneal injection; once daily for 6 weeks
Result:P301S transgenic mice treated with CCT020312 performed significantly better in Morris water maze.


分子量:650.40


Formula:C31H30Br2N4O2


CAS 號(hào)324759-76-4


運(yùn)輸條件:Room temperature in continental US; may vary elsewhere.


儲(chǔ)存方式:

Powder-20°C3 years
In solvent-80°C6 months

-20°C1 month


溶解性數(shù)據(jù)


In Vitro: 

DMSO : 100 mg/mL (153.75 mM; Need ultrasonic)

配制儲(chǔ)備液
濃度溶劑體積質(zhì)量1 mg5 mg10 mg
1 mM1.5375 mL7.6876 mL15.3752 mL
5 mM0.3075 mL1.5375 mL3.0750 mL
10 mM0.1538 mL0.7688 mL1.5375 mL
*

請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲(chǔ)備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?6 個(gè)月內(nèi)使用,-20°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?1 個(gè)月內(nèi)使用。

In Vivo:

以下溶解方案都請(qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液,再依次添加助溶劑:

——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比;如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過(guò)加熱和/或超聲的方式助溶

  • 1.


    請(qǐng)依序添加每種溶劑: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.08 mg/mL (3.20 mM); Clear solution


  • 2.


    請(qǐng)依序添加每種溶劑: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: 2.08 mg/mL (3.20 mM); Suspended solution; Need ultrasonic


  • 3.


    請(qǐng)依序添加每種溶劑: 10% DMSO    90% corn oil

    Solubility: ≥ 2.08 mg/mL (3.20 mM); Clear solution


參考文獻(xiàn)

[1]. Stockwell SR, et al.Mechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signalling. PLoS One. 2012;7(1):e28568.

[2]. Bruch J, et al. PERK activation mitigates tau pathology in vitro and in vivo. EMBO Mol Med. 2017 Mar;9(3):371-384.


CCT020312

CCT020312

分享到微信

×
CCT020312 是選擇性的 EIF2AK3/PERK 的激huo劑。CCT020312 可誘導(dǎo)細(xì)胞細(xì)胞中 EIF2A 的磷酸化。貨號(hào):HY-119240 ,CAS:324759-76-4
品牌:MCE
型號(hào):HY-119240
起訂量:1
規(guī)格::5mg
價(jià)格::¥1800
15906629305
在線客服
產(chǎn)品詳情

CCT020312

CCT020312 是選擇性的 EIF2AK3/PERK 的ji活劑。CCT020312 可誘導(dǎo)細(xì)胞細(xì)胞中 EIF2A 的磷酸化。

生物活性

CCT020312 is a selective EIF2AK3/PERK activator. CCT020312 elicits EIF2A phosphorylation in cells.


IC50 & Target

EIF2AK3/PERK[1][2].


體外研究(In Vitro)

Treatment of HT29 cells with CCT020312 for 24 hours reveals a concentration-dependent loss of P-S608-pRB signal, with a linear response between 1.8 and 6.1 μM[1].
CCT020312 treatment effectively inhibits cell proliferation (as measured at 96 hours) even if treatment is for 2 hours only with subsequent compound washout, indicating that CCT020312 is capable of eliciting durable rather than transient cytostasis[1].
Treatment of HT29 cells with 10 μM CCT020312 for 24 hours reduces the amount of the G1/S cyclins D1, D2, E and A as well as the CDK catalytic subunit CDK2 and increased the level of the CDK inhibitor p27KIP1 present in such cells[1].


體內(nèi)研究(In Vivo)

Treatment of 15-week-old wildtype mice with the PERK activator CCT020312 (1-5 mg/kg; i.p.; once daily for 3 days) leads to increased levels of phosphorylated PERK and NRF2 in brain homogenates[2].
P301S transgenic mice treated with CCT020312 (2 mg/kg; i.p.; once daily for 6 weeks) performes significantly better in Morris water maze[2].

Animal Model:9-week-old P301S tau transgenic mice[2]
Dosage:2 mg/kg
Administration:Intraperitoneal injection; once daily for 6 weeks
Result:P301S transgenic mice treated with CCT020312 performed significantly better in Morris water maze.


分子量:650.40


Formula:C31H30Br2N4O2


CAS 號(hào)324759-76-4


運(yùn)輸條件:Room temperature in continental US; may vary elsewhere.


儲(chǔ)存方式:

Powder-20°C3 years
In solvent-80°C6 months

-20°C1 month


溶解性數(shù)據(jù)


In Vitro: 

DMSO : 100 mg/mL (153.75 mM; Need ultrasonic)

配制儲(chǔ)備液
濃度溶劑體積質(zhì)量1 mg5 mg10 mg
1 mM1.5375 mL7.6876 mL15.3752 mL
5 mM0.3075 mL1.5375 mL3.0750 mL
10 mM0.1538 mL0.7688 mL1.5375 mL
*

請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
儲(chǔ)備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?6 個(gè)月內(nèi)使用,-20°C 儲(chǔ)存時(shí),請(qǐng)?jiān)?1 個(gè)月內(nèi)使用。

In Vivo:

以下溶解方案都請(qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液,再依次添加助溶劑:

——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比;如在配制過(guò)程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過(guò)加熱和/或超聲的方式助溶

  • 1.


    請(qǐng)依序添加每種溶劑: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.08 mg/mL (3.20 mM); Clear solution


  • 2.


    請(qǐng)依序添加每種溶劑: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: 2.08 mg/mL (3.20 mM); Suspended solution; Need ultrasonic


  • 3.


    請(qǐng)依序添加每種溶劑: 10% DMSO    90% corn oil

    Solubility: ≥ 2.08 mg/mL (3.20 mM); Clear solution


參考文獻(xiàn)

[1]. Stockwell SR, et al.Mechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signalling. PLoS One. 2012;7(1):e28568.

[2]. Bruch J, et al. PERK activation mitigates tau pathology in vitro and in vivo. EMBO Mol Med. 2017 Mar;9(3):371-384.


選擇區(qū)號(hào)